Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries under voluntary licence from ViiV Healthcare
Aurobindo Pharma Limited | 17/08/2023 | By Sudeep Soparkar | 167
CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar
CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar
Aurobindo Pharma Limited | 10/07/2023 | By Sudeep Soparkar | 446
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy